Mise à jour
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
Maladies infectieuses 2025BASE DE CONNAISSANCES MÉDICALES
Recommandations cliniques
Retrouvez les recommandations officielles, consensus et mises à jour publiés par les sociétés savantes et autorités de santé.
Sources officielles et fiablesSociétés savantes et autorités de santé
Informations mises à jourVeille scientifique continue
Accès gratuit pour les professionnelsAu service de la communauté médicale
APPLICATION ASEM
Des recommandations cliniques, où que vous soyez
Explorez les recommandations médicales officielles et les guides de pratique clinique dans l’application ASEM.
Télécharger l’application ASEMPublications et mises à jour importantes
Voir les publications récentes
Mise à jour
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
Cardiologie 2025
Publication officielle
WHO guidelines on the integrated management of obesity in adolescents
World Health Organization
Pédiatrie 2026Toutes les recommandations (524 résultats)
Filtres
Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11] ». Extrai...
Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikev...
Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17]
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in childr...
Archived 36: Summary of NACI statement of April 5, 2022: Initial guidance on a second booster dose of COVID-19 vaccines in Canada
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 36: Summary of NACI statement of April 5, 2022: Initial guidance on a second booster dose of...
Archived 36: Initial guidance on a second booster dose of COVID-19 vaccines in Canada [2022-04-05]
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 36: Initial guidance on a second booster dose of COVID-19 vaccines in Canada [2022-04-05] »....
Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID-19 vaccines in Canada
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of...
Archived 37: Updated guidance on a first booster dose of COVID-19 vaccines in Canada [2022-04-12]
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 37: Updated guidance on a first booster dose of COVID-19 vaccines in Canada [2022-04-12] ». E...
Archived 39: Summary of NACI statement of September 1, 2022: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 39: Summary of NACI statement of September 1, 2022: Recommendations on the use of bivalent Om...
Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01]
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09...
Archived 41: Summary of NACI statement of June 29, 2022: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 41: Summary of NACI statement of June 29, 2022: Interim guidance on planning considerations f...